Guard Therapeutics International AB (publ) reported earnings results for the fourth quarter ended December 31, 2023. For the fourth quarter, the company reported net loss was SEK 17.1 million compared to SEK 40.49 million a year ago.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
29.6 SEK | -0.67% | +2.78% | -17.32% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.32% | 27.35M | |
+1.51% | 42.75B | |
+47.98% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- GUARD Stock
- News Guard Therapeutics International AB
- Guard Therapeutics International AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023